Read Amy Dockser's WSJ article today and revisited XMRV developments. Its been months since I have bothered to update. XMRV research is still a mess. Marguerite at VIPdx was called, and she says something is in the works but not finalized for prior test patients. Perhaps they will be antibody testing the old blood samples, or maybe they will want new blood samples. No mention of costs, etc. They will send out letters to patients when they get it all figured out.